📈 The Tape Reader

Friday, November 20, 2026

11 stories · Standard format

Generated with AI from public sources. Verify before relying on for decisions.

🎧 Listen to this briefing or subscribe as a podcast →

Options expiration week is ending with a massive liquidity vacuum, as Anthropic's mega-IPO and hawkish Fedspeak force cascading liquidations across mega-cap technology and drive capital straight into defensive healthcare.

Market Internals & Flow

SPX Breaches 7,150 Pivot as Dealer Short Gamma Accelerates OpEx Liquidation

Yesterday we tracked market makers shifting into a -$102.1 billion short gamma posture as SPX breached 7,300; today, aggregate dealer short gamma across index products has expanded past -$112 billion heading into Friday's monthly options expiration. S&P 500 spot price touched 7,158.40, pinning the major 7,150 level (-136M MM exposure) while the VIX reached 29.6 and front-month volatility inverted past 32.0.

When market makers operate in deeply negative short gamma, their mechanical requirement to sell delta into declining prices eliminates traditional bid support, creating fast intraday trend days. For trading operations, operating without local dealer brakes means standard mean-reversion order flow fails until spot reclaims the 7,225/7,250 absolute call node. Monitoring 5-minute bar closes relative to the 7,110 put floor provides the primary boundary for managing short-side intraday acceleration versus opex pin plays.

Verified across 9 sources: Saxo Bank · Hmaquant · Coffee With Q · SpyOptions · SpyOptions Actionable Levels · VolArchitect · Saxo Bank · AlgoIndex · Investing.com

Episodic Pivots

Bloom Energy Rips 8.8% on BMO Upgrade to Outperform with $230 Target

Bloom Energy (BE) surged 8.8% on Friday, closing near $186.02 on high volume of 3.3 million shares after BMO Capital Markets upgraded the stock from Market Perform to Outperform with a $230 price target. The upgrade builds upon Bloom's Q3 report where quarterly revenue jumped 138% year-over-year to $1.24 billion, driven by expanding commercial contracts for on-site power generation at AI data-center facilities.

Bloom Energy offers a clear episodic pivot setup where a tier-1 desk upgrade validates a fundamental revenue inflection tied to physical power infrastructure demand. The high volume signature breaking out of a multi-week consolidation base demonstrates institutional sponsorship absorbing secondary market weakness. Swing traders should target continuation entries above the $185 breakout level, using a daily close below $172 for trade invalidation.

Verified across 3 sources: Defense World · StockTwits · Yahoo Finance

Anthropic Gains 17% on Nasdaq Debut as $81.3B IPO Siphons Tech Liquidity

Yesterday we covered Anthropic's massive $81.3 billion IPO pricing at $83 per share; today, the stock (ANT) opened at $111.50 in its Nasdaq debut before closing up 17.07% at $97.17. While the $1.5 trillion AI firm successfully absorbed over $500 billion in order-book demand, the immense primary liquidity draw sparked severe secondary distribution across semiconductor and mega-cap software names, dragging the Nasdaq down 2.2%.

Anthropic's public debut acted as a massive capital extraction event, forcing institutional desks to liquidate liquid semiconductor holdings to fund allocations in the primary listing. For swing desks, tracking the post-open price discovery of ANT above its $83 IPO floor provides a barometer for broader tech risk appetite. If ANT breaks below its opening drive low of $95, secondary tech liquidations are likely to accelerate across high-beta proxies.

Verified across 9 sources: TradingView · Trade and Ticker · Yahoo Finance · CNBC · MacNicol Asset Management · Substack · Longbridge · Market Rebellion · Tickmill

SELLAS Life Sciences Prices $150M Offering at $13 After 156% Phase 3 REGAL Spike

Following the positive Phase 3 REGAL trial data we tracked earlier this week that sent shares surging, SELLAS Life Sciences (SLS) closed regular hours up 156.4% at $19.15 on 120 million shares. After Wednesday's close, the company aggressively capitalized on the momentum, pricing a $150 million underwritten public offering of 11.54 million shares at $13.00 per share—a 32% discount to the prior session close.

This represents a classic biotech binary catalyst where explosive episodic momentum is immediately capped by a heavily discounted secondary offering overhang. The influx of 11.54 million new shares at $13.00 creates a massive structural supply wall that short-term traders must respect. Active operators should avoid buying initial bounces until VWAP stabilizes above the $13.00 offering floor and short interest digestion is confirmed.

Verified across 1 sources: IndicatorStack

Earnings Gappers

Bending Spoons Surges 11% Premarket on Mailchimp Acquisition and Q3 Beat as Intuit Drops 13%

In Thursday after-hours action, Bending Spoons surged 11% following Q3 EPS of $0.42 on $780.2 million in revenue and an agreement to acquire Mailchimp from Intuit for $3.68 billion. Conversely, Intuit (INTU) tumbled 13.88% after hours to $278.58 despite posting fiscal Q1 EPS of $2.91, as management issued soft full-year revenue guidance accompanying the Mailchimp divestiture.

The transaction creates a distinct paired earnings setup: Bending Spoons gains immediate scale and asset catalyst momentum, while Intuit faces aggressive multiple compression due to decelerating core guidance. For pre-market gap strategies, INTU presents a prime short-side continuation candidate if opening VWAP fails at $280, whereas Bending Spoons provides a long-side gap-and-go setup if volume confirms above post-market resistance.

Verified across 3 sources: TradingView · Investing.com · Benzinga

Gap Inc Gaps Up 4% on Q3 EPS Beat Despite Full-Year Guidance Trim

Gap Inc. (GPS) gapped up 4% in extended trading after reporting fiscal Q3 adjusted EPS of $0.82 on $4.01 billion in sales, topping consensus estimates of $0.78. Bottom-line outperformance was led by 11% net sales growth at the core Gap brand, which offset a 15% comp decline at Athleta. Management appointed Ashley Kechter as Athleta Brand President while trimming full-year EPS guidance to $2.29–$2.34 from $2.35–$2.45 due to unseasonably warm fall weather.

Gap's gap-up highlights a clear tug-of-war between margin-driven EPS execution and top-line brand deceleration at Athleta. Institutional sponsorship is stepping in to support the core brand's turnaround, providing defined entry parameters above the $22.50 pre-market pivot. Swing traders should watch whether opening volume can absorb the headline guidance cut or if the move fades into daily moving average resistance.

Verified across 3 sources: Benzinga · 24/7 Wall St. · Investing.com

Parabolic Long/Short

AMD Drops 7.7% Following Hunterbrook Short Report Alleging China Export Vulnerabilities

Advanced Micro Devices (AMD) tumbled 7.7% to an intraday low of $470.56 before stabilizing near $489.17 after short-seller Hunterbrook Capital published a report on Thursday alleging export restriction workarounds and firmware compliance risks in Chinese server channels. The sell-off occurred despite AMD's recent Q3 report confirming server market share gains to 35.5% and 97% year-over-year data-center revenue growth to $7.05 billion.

Headline-driven short reports on liquid mega-cap leaders often create extreme short-side volatility and high-asymmetry mean-reversion setups. Because AMD's balance sheet is supported by robust cash flows and expanding server market share, the panic flush toward $470 represents an exhaustion setup if key support holds. Day traders can structure tactical long bounce trades risking against the $450 low with upside targets near $540 once headline selling abates.

Verified across 5 sources: Yahoo Finance · Investing.com · Substack · TradeVae · Saxo Bank

Analyst Actions

UBS Upgrades MongoDB to Buy with $450 Target Citing Enterprise AI Vector Database Traction

UBS upgraded MongoDB (MDB) from Neutral to Buy on Thursday, raising its price target to $450.00 from $365.00. Analyst Karl Keirstead cited accelerating consumption metrics for Atlas and expanding enterprise adoption of MongoDB's integrated vector search capabilities for AI applications as structural growth drivers.

Tier-1 desk upgrades carrying substantial target deltas (+23% upside) serve as key catalysts for institutional repositioning during market pullbacks. MDB has demonstrated strong relative strength relative to broader software benchmarks, making this upgrade an actionable trigger for swing traders seeking high-beta continuation plays. A daily close above the $390 technical pivot validates institutional accumulation.

Verified across 3 sources: StockTwits · CNBC · Yahoo Finance

Mean Reversion Setups

UnitedHealth Plunges 18% Over 5 Days as CMS RADV Audit Rule Sparks Panic Washout

UnitedHealth Group (UNH) tumbled another 5% on Thursday to trade at $330.48 on 3.12x average daily volume, extending a 5-day drop of 18% following CMS's proposed CRUSH rule and aggressive Medicare Advantage RADV audit extrapolation. The stock sits 10% below its 200-day moving average with an oversold 14-day RSI of 24.2. Goldman Sachs issued a note defending UNH, arguing the drop reflects policy sentiment rather than fundamental cash flow destruction.

The multi-day panic flush in UNH has driven technical indicators into deeply washed-out territory while off-exchange options volume reflects extreme institutional hedging. While catching falling knives without volume confirmation is high-risk, the divergence between institutional policy analysis and emotional retail selling sets up a high-reward mean-reversion bounce. Traders should monitor for an intraday high-volume reversal hammer above $330 before deploying tactical long swing capital.

Verified across 4 sources: duanjl.com · TradersDaily · Global Stock Brief · Investing.com

Sector Rotation & Themes

Capital Rotates to Healthcare and Staples ETFs as Semiconductor Funds Suffer Outflows

Building on the historic 25-year defensive rotation we tracked earlier this week, institutional flow data through November 19 reveals a continued massive sector shift out of high-multiple technology into defensive cash-flow plays. While semiconductor ETFs like SOXL experienced 20% drawdowns over 24 hours and hardware leaders faced steep monthly liquidations, healthcare benchmark XLV has gained 24% over six months, with flows accelerating into non-tech beneficiaries including IDEXX Labs (+23.6% 1-mo) and Chipotle (+22.4% 1-mo).

This capital flight confirms a broad thematic migration away from capex-heavy AI hardware toward resilient, high-free-cash-flow enterprise software, healthcare, and defensive consumer names. Active swing traders should adjust sector filters to prioritize long setups in defensive relative-strength leaders while utilizing technical bounces in battered tech names primarily for short-side re-entries.

Verified across 4 sources: Investing.com · Zacks Investment Research · Morningstar · Global Stock Brief

Catalyst-Driven News

Savara Trades at 13x Book Value Ahead of Sunday's Binary FDA Decision on Molgramostim

Savara Inc. (SVRA) shares are trading at a price-to-book multiple of 13.0x heading into the FDA's extended Prescription Drug User Fee Act (PDUFA) action date on Sunday, November 22, 2026, for molgramostim (MOLBREEVI) in autoimmune pulmonary alveolar proteinosis. Implied options volatility has expanded significantly across November contracts as parallel regulatory reviews proceed in Europe and the UK.

Savara presents a binary regulatory catalyst where valuation multiples are severely extended relative to the biotech industry average of 1.7x book. This extreme pricing leaves zero margin for execution errors or conditional approval delays. Swing traders holding position exposure into Sunday must account for binary gap risk, while options operators can exploit elevated implied volatility skew for post-event volatility crush strategies.

Verified across 1 sources: Yahoo Finance


The Big Picture

Negative Dealer Gamma Amplifies Broad Liquidation Cascades As the S&P 500 breaches critical put walls, market makers operating in deeply negative short gamma regimes are forced to sell into market declines and buy into rallies, accelerating momentum past traditional support levels into monthly options expiration.

Hawkish Fed Expectations Drive Cross-Asset Repricing Synchronized hawkish commentary from Fed officials and persistent inflationary pressures are driving December rate-hike odds past 95%, pinning Treasury yields near multi-year peaks and draining liquidity from non-yielding growth assets.

Primary AI Liquidity Siphons High-Beta Tech Exposure Anthropic's massive public debut has drawn hundreds of billions in institutional capital, triggering secondary distribution across mega-cap tech and semiconductor leaders as funds reallocate exposure.

Defensive Capital Reallocation Toward Cash-Generative Sectors Institutions are aggressively reducing hardware cyclicals and over-leveraged tech proxies, directing capital flow into non-AI defensive sectors including managed care, pharmaceutical biotechs, and essential utilities.

Extreme Breadth Washouts Trigger High-Asymmetry Reversion Setups Widespread multi-day index declines and collapsed moving-average breadth have pushed momentum indicators into deeply depressed territory, opening tactical mean-reversion windows in quality names.

What to Expect

2026-11-22 — FDA PDUFA target action date for Savara's molgramostim (MOLBREEVI) in autoimmune PAP.
2026-12-10 — CEL-SCI complete response submission to U.S. FDA targeting resolution of Multikine clinical hold.
2027-01-01 — Implementation date for Saudi Food and Drug Authority New Accelerator Program guidance.
2027-03-10 — FDA Priority Review decision date for Intellia Therapeutics' lonvo-z in hereditary angioedema.

Every story, researched.

Every story verified across multiple sources before publication.

🔍

Scanned

Across multiple search engines and news databases

576
📖

Read in full

Every article opened, read, and evaluated

133
⭐

Published today

Ranked by importance and verified across sources

11

— The Tape Reader

🎙 Listen as a podcast

Subscribe in your favorite podcast app to get each new briefing delivered automatically as audio.

Apple Podcasts
Library tab → ••• menu → Follow a Show by URL → paste
Overcast
+ button → Add URL → paste
Pocket Casts
Search bar → paste URL
Castro, AntennaPod, Podcast Addict, Castbox, Podverse, Fountain
Look for Add by URL or paste into search

Spotify isn’t supported yet — it only lists shows from its own directory. Let us know if you need it there.